PhiTech, a biotech startup developing genomics and AI-driven solutions, has raised $2.4 million
PhiTech, a biotechnology company integrating genomics and artificial intelligence to address rare diseases, has raised $2.4 million in funding.
.webp&w=3840&q=75)
PhiTech, a biotechnology company integrating genomics and artificial intelligence to address rare diseases, has raised $2.4 million in funding.
The investment round was led by Entertech Venture Capital Fund (GSYF), established through a collaboration between Entertech İstanbul Teknokent and Yapı Kredi Portfolio. The round also saw participation from Eksim Ventures, Founder One, İTK Ventures, TechnoBee, Arya VC, İstcapital, Gelecek Etki GSYF, along with a group of angel investors including Muharrem Usta, Kamil Buğra Rodoper, Banu Başaran, Mert Erdoğmuş, Ahmet Kemal Atasoy, Dr. Adem Akkaya, Zeynep Seval, Selami Düz, Candan Karabağlı, and Osman Alp Arlı.
The company plans to use the funding to scale its multi-layered AI solutions focused on rare diseases and to advance the R&D of its oncology-oriented products.
Founded in 2013 by Dr. Saliha Durmuş, Prof. Tunahan Çakır, and Prof. Fatih Erdoğan Sevilgen, PhiTech has developed its proprietary G&M (Genomics & More) platform, enabling integrated analysis of DNA and RNA data. This approach enhances both diagnostic speed and accuracy, particularly in rare diseases and oncology.
By moving beyond traditional DNA-only genetic testing, PhiTech leverages multi-layered data analysis to deliver clinically actionable insights. Its platform supports hospitals, genetic diagnostic laboratories, and pharmaceutical companies in clinical decision-making, patient management, and drug development—contributing to faster diagnoses and the broader adoption of precision medicine.
Related News
Terra Industries, an Africa-based defense technology startup, has secured an additional $18 million in funding
Terra Industries, a Nigerian defense technology startup, added another $18 million to its seed funding round, bringing the total seed investment to $52 million.
Build, an AI-powered infrastructure health monitoring platform, has raised $8.5 million in funding
The U.S.-based artificial intelligence startup Build has secured an $8.5 million seed investment for its platform, developed to automate due diligence processes used in infrastructure projects...
Conduct, a software startup focused on modernizing SAP systems, has raised $60 million in funding
ICONIQ Capital, which has previously invested in tech giants such as Snowflake, Databricks, Anthropic, and ElevenLabs, has now turned its attention to a young London-based startup.